NASH patients exhibited lower serum levels of IGF-1 (104 ng/mL) compared to those in the NAFLD patients without NASH (123 ng/mL, p < 0.002). The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatotic liver disease.